Pharm: What about Worsening Symptoms: Role of New Drugs.

Select a ModuleModule DetailsReview MaterialsEvaluate ModulePrint Certificate


Robert DiDomenico, PharmD

Learning Outcomes:

  • Highlight the mechanism of action, pharmacokinetics, side effects, contraindications, and monitoring parameters for omecamtiv and vericiguat.
  • Examine current outcomes for omecamtiv and vericiguat regarding in the management of HFrEF
  • Delineate the role of for omecamtiv and vericiguat in the management of HFrEF

This activity is approved for 0.75 contact hour(s) of continuing education by the American Association of Nurse Practitioners®. Activity ID# 22055477. This activity was planned in accordance with AANP Accreditation Standards and Policies.